Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer

Algars A, Irjala H, Vaittinen S et al (2012) Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 131:864–873

Chai CY, Chen WT, Hung WC et al (2008) Hypoxia inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 61:658–664

Chaput N, Louafi S, Bardier A et al (2009) Identification of CD8+ CD25+ Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58:520–529

Cui YL, Li HK, Zhou HY et al (2013) Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. Asian Pac J Cancer Prev 14:1003–1007

Forssell J, Oberg A, Henriksson ML et al (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13:1472–1479

Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12:253–268

Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964

Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593

Grimmig T, Kim M, Germer CT et al (2013) The role of FOXP3 in disease progression in colorectal cancer patients. Oncoimmunology 2:e24521

Gulubova M, Ananiev J, Yovchev Y et al (2013) The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients’ survival. J Mol Histol 44:679–692

Hiraoka N, Onozato K, Kosuge T et al (2006) Prevalence of FOXP3 regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434

Ferlay J,  Soerjomataram I,  Dikshit R et al  (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-E386. doi: 10.1002/ijc.29210

Kim M, Grimmig T, Grimm M et al (2013) Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One 8:e53630

Kobayashi N, Hiraoka N, Yamagami W et al (2007) FOXP3 regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13:902–911

Kryczek A, Zou I, Rodriguez P et al (2006) B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203:871–881

Ladoire S, Martin F, Ghiringhelli F (2011) Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60:909–918

Ling KL, Pratap SE, Bates GJ et al (2007) Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7:7–12

Loddenkemper C, Schernus M, Noutsias M et al (2006) In situ analysis of FOXP3 regulatory T cells in human colorectal cancer. J Transl Med 4:52–59

Merlo A, Casalini P, Carcangiu ML et al (2009) FOXP3 expression and overall survival in breast cancer. J Clin Oncol 27:1746–1752

Michel S, Benner A, Tariverdian M et al (2008) High density of FoxP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99:1867–1873

Muc-Wierzgoń M, Nowakowska-Zajdel E, Dzięgielewska-Gęsiak S et al (2014) Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer. World J Gastroenterol 29:9759–9774

Ohtani H (2007) Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 7:4–8

Pages F, Berger A, Camus M et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666

Piktel E, Niemirowicz K, Wnorowska U et al (2016) The role of cathelicidin LL-37 in cancer development. Arch Immunol Ther Exp 64:33–46

Ramanathan S, Gagnon J, Ilangumaran S (2008) Antigen-nonspecific activation of cytokines; T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer. Arch Immunol Ther Exp 56:311–323

Salama P, Phillips M, Grieu F et al (2009) Tumor-infiltrating FOXP3 T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192

Sasada T, Kimura M, Yoshida Y et al (2003) CD4+ CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089–1099

Shih JY, Yuan A, Chen JJ et al (2006) Tumor-associated macrophage: its role in cancer invasion and metastasis. J Cancer Mol 2:101–106

Takenaka N, Seki U, Toh S et al (2013) FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis. Mol Clin Oncol 1:625–632

Tan SY, Fan Y, Luo HS et al (2005) Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 11:1210–1214

Tsutsui S, Yasuda K, Suzuki K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431

Xue L, Lu HQ, He J et al (2010) Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data. Dis Esophagus 23:340–346

Zhou Q, Peng RQ, Wu XJ et al (2010) The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 8:8–13

Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295–307